Gene News and Research

Latest Gene News and Research

Evonetix closes $24 million USD (£20 million) financing

Funding will enable development of DNA synthesis chip technology to commercial scale.

From Evonetix 7 Feb 2023

Newly identified gene signature helps assess cancer risk and optimize treatment

In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader in the Molecular & Cellular Oncogenesis Program, and team have identified a gene signature that accurately predicts the functioning of P53 variants, important information to assessing cancer risk and optimizing choices for cancer therapeutics.

7 Feb 2023

Lonza delivers strong 2022 performance with 15.1% CER sales growth and 32.1% CORE EBITDA margin

Lonza has reported sales of CHF 6.2 billion, sales growth of 15.0% AER (15.1% CER), and CHF 2.0 billion CORE EBITDA, resulting in a margin of 32.1%. These robust financial results are driven by strong underlying business performance and a COVID-related sales peak in 2022 which enhanced both sales and margin.

From Lonza 7 Feb 2023

New research may explain why some patients suffer from long-COVID

A review article published in The Journal of Clinical Investigation deciphers the relationship between rare inborn errors of type I interferon immunity and the development of severe coronavirus disease 2019 (COVID-19) pneumonia.

6 Feb 2023

A novel multiplexed assay to diagnose Mpox and other viruses

Researchers evaluate the performance of novel assay to identify Mpox viral infection.

6 Feb 2023

Researchers identify a new genetic risk factor for age-related macular degeneration

Researchers at Tel Aviv University identified a new genetic risk factor for the complex eye disease AMD (Age-related Macular Degeneration), a leading cause for loss of eyesight at an advanced age.

6 Feb 2023

Detecting novel SARS-CoV-2 variants via rapid RT-PCR assays

A new study on the medRxiv* preprint server assessed whether a novel assay could detect VOCs without substantial reductions in sensitivity.

6 Feb 2023

Cardiovascular risk in psoriasis, the association between psoriatic inflammation and atherosclerosis, and the cardiovascular-risk-reducing effects of biologics

Researchers explored the impact of biological interventions in reducing cardiovascular risk among psoriasis patients.

6 Feb 2023

New type of immunotherapy effective in mice with ovarian cancer

CAR T-cell therapy, a certain kind of cancer treatment in which the immune system's T cells are programmed to attack tumor cells, is effective in mice with ovarian cancer, according to a study published in The Journal for ImmunoTherapy of Cancer.

6 Feb 2023

Study suggests that both mother and infant can contribute to the human milk microbiome

Researchers examined associations between the bacterial composition of human milk and maternal and infant factors.

6 Feb 2023

MIT study helps shed light on why the immune system mounts a dull response to lung cancer

Immunotherapy - drug treatment that stimulates the immune system to attack tumors - works well against some types of cancer, but it has shown mixed success against lung cancer.

3 Feb 2023

UT Southwestern research could lead to new ways of controlling gene regulation

UT Southwestern Medical Center researchers have discovered a method cells use to turn genes on and off that involves portions of proteins whose function has long been a mystery.

3 Feb 2023

Deletion of a tumor suppressor gene promotes luminal breast cancer development and resistance to endocrine therapy

A research team from LKS Faculty of Medicine, the University of Hong Kong (HKUMed) discovered that somatic deletion of a tumor suppressor gene AKTIP promotes luminal breast cancer development and resistance to endocrine therapy.

3 Feb 2023

World Cancer Day 2023: Perspectives from The Institute of Cancer Therapeutics

To commemorate World Cancer Day, we spoke to a multidisciplinary team of researchers from The Institute of Cancer Therapeutics (ICT) based at the University of Bradford about their work in cancer research.

3 Feb 2023

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Cerba Research announced today a Memorandum of Understanding with Teddy Clinical Research Laboratory (Wuxi, China), a preeminent central lab provider covering mainland China, to lay the foundation for an in-depth discussion towards the creation of a Joint Venture.

From Cerba Research 3 Feb 2023

The human body develops strategies to prevent the immune response from overshooting its mark

The signaling molecules of the immune system should trigger a response only where necessary. To prevent a life-threatening spread to the rest of the body, connective tissue can absorb these molecules like a sponge.

3 Feb 2023

Pulmonary surfactant-mediated inflammatory response against SARS-CoV-2

Researchers discuss the role of a surfactant-mediated inflammatory response employed by human lungs against SARS-CoV-2.

3 Feb 2023

Researchers develop a cell line to address the challenges facing cellular modeling of disease

Bill Skarnes and team established and characterized a stable iPSC line, KOLF2.1J, to act as a high-quality baseline platform for modeling human disease.

3 Feb 2023

Unexpected discovery may lead to improved treatments for YAP fusion-driven cancers

An unexpected discovery made by experts at the Brain Tumor Center at Cincinnati Children's while studying a rare-but-deadly type of brain tumor may also lead to improved treatments for several other forms of cancer that share a common influencing factor called a YAP fusion protein.

2 Feb 2023

Understanding the mechanism of bedaquiline resistance in Mycobacterium marinum

Announcing a new article publication for Zoonoses journal. As infections caused by nontuberculous mycobacteria (NTM) are rapidly increasing globally, a need exists for developing novel antibiotics and discovering the mechanism of resistance

2 Feb 2023

Gene News and Research

Latest Gene News and Research

Evonetix closes $24 million USD (£20 million) financing

Newly identified gene signature helps assess cancer risk and optimize treatment

Lonza delivers strong 2022 performance with 15.1% CER sales growth and 32.1% CORE EBITDA margin

New research may explain why some patients suffer from long-COVID

A novel multiplexed assay to diagnose Mpox and other viruses

Researchers identify a new genetic risk factor for age-related macular degeneration

Detecting novel SARS-CoV-2 variants via rapid RT-PCR assays

Cardiovascular risk in psoriasis, the association between psoriatic inflammation and atherosclerosis, and the cardiovascular-risk-reducing effects of biologics

New type of immunotherapy effective in mice with ovarian cancer

Study suggests that both mother and infant can contribute to the human milk microbiome

MIT study helps shed light on why the immune system mounts a dull response to lung cancer

UT Southwestern research could lead to new ways of controlling gene regulation

Deletion of a tumor suppressor gene promotes luminal breast cancer development and resistance to endocrine therapy

World Cancer Day 2023: Perspectives from The Institute of Cancer Therapeutics

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

The human body develops strategies to prevent the immune response from overshooting its mark

Pulmonary surfactant-mediated inflammatory response against SARS-CoV-2

Researchers develop a cell line to address the challenges facing cellular modeling of disease

Unexpected discovery may lead to improved treatments for YAP fusion-driven cancers

Understanding the mechanism of bedaquiline resistance in Mycobacterium marinum

Genomics - Industry Focus eBook (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson